Trial site
Kolkata
- 7running trials
- 13closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Familial hypercholesterolaemia3 trials
- Chronic myeloid leukaemia2 trials
- Chronic spontaneous urticaria2 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Multiple sclerosis2 trials
- Coronary artery disease1 trial
- Diabetic eye disease1 trial
- Gastric and oesophageal cancer1 trial
- IgA nephropathy1 trial
- Immune thrombocytopenia (ITP)1 trial
- Myelodysplastic syndromes1 trial
- and 4 more
- Phase
- Phase 313 trials
- Phase 46 trials
- Status
- Completed12 trials
- Active, not recruiting6 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Completed
Completed
Completed
Completed
Completed
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026